High expression ofFAMLFis associated with clinical response in patients withde novoacute myeloid leukemia-Reference-Cited by-同舟云学术

High expression ofFAMLFis associated with clinical response in patients withde novoacute myeloid leukemia

Published:2016-04-11 Issue:11 Volume:57 Page:2727-2730
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Wang Shao-Yuan,Chen Wan-Ling,Wang Ze-Chuan,Li Xiao-Fan,Lin Sheng-Long,Gao Chao,Huang Yuan-Mao,Luo Dong-Feng,Li Jing-Gang,Zi You-Mei,Yi Zheng,Lin Yun,Lai Laijun,Pan Li-Li

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2016.1160087

Reference12 articles.

1. Adult Acute Leukemia

2. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia

3. High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder

4. Somatic CEBPA Mutations Are a Frequent Second Event in Families With Germline CEBPA Mutations and Familial Acute Myeloid Leukemia

5. Familial myelodysplasia and acute myeloid leukaemia - a review

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MiR-181b Inhibits the Proliferation of Lymphoma Rajixi Cell Line by Regulating the Expression of Target Gene FAMLF;Cellular and Molecular Biology;2022-02-27

2. Feasibility of portal or superior mesenteric vein resection and reconstruction by allogeneic vein for pancreatic head cancer—a case-control study;BMC Gastroenterology;2018-04-16

3. Lentivirus-mediated RNA interference targeting FAMLF-1 inhibits cell growth and enhances cell differentiation of acute myeloid leukemia partially differentiated cells via inhibition of AKT and c-MYC;Oncotarget;2017-09-26

4. Wang, S.-Y., Chen, W.-L., Wang, Z.-C., et al. High expression of FAMLF is associated with clinical response in patients with de novo acute myeloid leukemia. Leuk. Lymphoma 2016. http://dx.doi.org/10.3109/10428194.2016.1160087;Leukemia & Lymphoma;2016-05-17